Omega 3 Market (2026 - 2033)

Omega 3 Market Summary

The global omega 3 market size was valued at USD 3.8 billion in 2025 and is projected to grow from USD 4.0 billion in 2026 to USD 6.6 billion in 2033, at a CAGR of 7.4% from 2026 to 2033. North America dominated with a revenue share of more than 37.0% in 2025. This is attributable to the rising use of ingredients in the human diet to support brain and heart health.

Furthermore, the increasing consumer investment in healthcare and one’s well-being is also expected to boost product demand. The market is witnessing continuous diversification in its product offerings as consumers are looking for alternatives to traditional fish oil. Krill oil is one of the widely used sources of omega-3 due to its superior properties as compared to conventional fish oil. The majority of consumers in Europe and North America prefer krill oil over any other source of fish oil owing to its acid reflux, unpleasant taste, and large-sized pills. Such factors are anticipated to trigger product demand during the forecast period.

The demand for omega-3 fatty acids in the U.S. is projected to grow significantly over the next few years owing to rising consumer awareness in the country regarding the several health benefits offered. In July 2025, the total global volume of omega-3 ingredients was 131,183 metric tons, a 2.5% increase in 2024 as comparison to 2023 including lowering blood pressure and cholesterol and reducing risks related to heart diseases. Moreover, growing consumer preference for a healthy and nutritional diet is further expected to fuel product demand shortly.

Numerous manufacturers present in the U.S., including BioProcess Algae, Martek Biosciences Corporation, and Omega Protein Corporation are focusing on research and development activities for launching pharmaceutical-grade product in the market. For instance, in March 2026, Aker BioMarine reported continued growth in its human health business, supported by increasing global demand for science-backed omega-3 ingredients derived from krill and microalgae, highlighting the industry's focus on innovation and premium nutritional solutions. Increasing consumption of enhanced medicines to treat and prevent chronic diseases is likely to spur overall consumption in the coming years.

Rising pressure on anchovy fisheries to extract fish oil has increased the demand from non-fish sources, including flaxseed, walnuts, algae, and krill oil. For instance, in March 2025, dsm-firmenich, the leading innovator in health, nutrition, and beauty announces it has won its patent infringement case against Canada-based Mara Renewables Corporation and its UK subsidiary Algal Omega-3 (together "Mara/AO3"). Furthermore, increasing government initiatives to promote product usage in different end-use applications are projected to positively impact the market demand.

Analyst Perspective

The market for omega-3 will continue to show strong growth as a result of increased consumer awareness of preventive healthcare as well as the health benefits of omega-3 fatty acids. It is observed that there is a significant shift towards high-value sustainable sources of omega-3 such as krill oil and algae ingredients, which have improved bioavailability and reduced environmental impact. The recent developments in the industry, including the increase in global supply of omega-3 ingredients and investments made by companies such as Aker BioMarine and dsm-firmenich, reflect strong faith in the market potential for future growth.

Increased research activity, greater utilization of omega-3 in the form of pharmaceutical grade omega-3, and demand for vegetarian and other non-conventional sources of marine omega-3 are expected to create new opportunities for manufacturers. Since health-conscious consumers are increasingly including omega-3 supplements in their daily health routines, the market is likely to perform well on account of steady demand for dietary supplements, functional foods, and pharmaceutical applications.

Type Insights

Docosahexaenoic acid (DHA) dominated the market with a revenue share of more than 56.0% in 2025. This is attributed to the growing utilization of the product in infant formulas to improve an infant's overall health. In the human diet, DHA is the most essential and abundant omega-3 fatty acid, which helps maintain the health of the human body.

DHA is a crucial component for developing and maturing an infant's brain and eyesight. Moreover, it is widely used in nutritional supplements and fortified foods. It is also used in treating dementia, attention deficit hyperactivity disorder, coronary artery disease (CAD), and Type 2 diabetes. The advantages of DHA for health and longevity have also resulted in its use in geriatric nutrition products.

Omega-3 PUFAs, including DPA, have been associated with cardiovascular health benefits. They may help reduce the risk of heart disease by lowering triglyceride levels, reducing inflammation, improving blood vessel function, and reducing the risk of arrhythmias. In addition, omega-3 PUFAs are crucial for brain health and development. While DHA is the most studied omega-3 PUFA in the brain, there is growing evidence suggesting the unique effects of DPA. DPA has been linked to neuroprotective properties and may have potential benefits in neurodegenerative and neurological disorders.

The demand for Eicosapentaenoic acid (EPA) will increase globally during the forecast period owing to several health benefits, such as avoiding inflammation, high blood pressure, coronary heart diseases, and excessive triglycerides (blood fats). It is also used for treating diabetes, addressing chemotherapy-related side effects, and enabling recovery from surgeries, among others.

Source Insights

The marine source dominated the market with the highest revenue share of more than 84.0% in 2025. This is attributable to the abundance of DHA and EPA omega-3s in fish bodies or oily, liver oil, or fatty fish, and marine microorganisms, such as marine and algae omega 3 ingredient including krill. High-omega-3 content sources for human consumption include salmon, pollock, tuna, and mackerel.

Other high EPA and DHA content sources include forage fish species with small bodies. This fish category includes anchovies, herring, sardines, mackerel, hoki, and capelin. Thus, marine, in general, is recognized worldwide as a major source of EPA and DHA, thereby leading to rising demand for omega-3 obtained from marine sources.

The plant source segment is expected to register growth over the forecast period, mainly because the global demand for vegetable oils obtained from seeds of soybeans, safflower, sunflower, cotton, and corn is surging as they are rich sources of omega 3. Key players are also shifting to plant sources as an alternative to fish oil due to their environmental benefits. For instance, in March 2025, dsm-firmenich announced that it had successfully defended its algal omega-3 intellectual property portfolio in the UK. Moverover, Nordic Naturals Algae Omega is a popular product in the market that provides vegans and vegetarians with a safe, sustainable, and reliable plant-based source of omega-3s EPA and DHA in high-quality algae oil. It supports brain, eye, and heart wellness, as well as immune system function.

Application Insights

Supplements & functional foods dominated the market with a revenue share of over 51.0% in 2025. This is attributable to the exceptional benefits offered by the product such as muscle gain, mineral fortification weight management, and beauty benefits. Growing awareness of reduced calorie intake among athletes and gym professionals in key countries such as India, Italy, China, and the U.S. is likely to promote the use of sports supplements and functional food products.

The pharmaceuticals segment is expected to register significant growth over the forecast period, driven by increasing use in the dermatology sector for its scalp-nourishment properties. It is used to preserve the lipid content of the skin, thus preventing moisture loss, and maintaining skin hydration. The rising utilization of omega 3 in pharmaceutical applications to treat the aforementioned skin and scalp conditions is further expected to drive the market over the forecast period.

The growing aging population, increasing lifestyle-related diseases, and rising prevalence of cancer are expected to fuel the demand for omega-3-based pharmaceutical products. For instance, in May 2025, FDA approval and encouraging launch of TRYNGOLZA (olezarsen) for people living with familial chylomicronemia syndrome (FCS) and also for the treatment of severe hypertriglyceridemia evaluating through Phase 3 CORE and CORE2 studies in Q3 2025. In addition, technological advancements in active pharmaceutical ingredient (API) manufacturing are expected to drive product market growth during the forecast period.

Regional Insights

North America region dominated the market with a revenue share of more than 37.0% in 2025. The demand in this geographical area is stimulated by the existence of prominent pharmaceutical corporations, including Pfizer, Inc., Johnson & Johnson, Amway, and Amarin Pharma, Inc., among other entities.

The rising consumption of omega-3 in the pharmaceuticals industry and the growing research and development activities related to the product are expected to drive the growth of the market in North America over the forecast period. Moreover, the rising consumption of omega 3-rich supplements and functional food products by athletes owing to their ability to improve protein synthesis, increase muscle health, and enhance the physical performance of consumers is anticipated to further drive the market growth over the forecast period.

Europe Omega 3 Market Trends

Europe, the demand for omega 3 is anticipated to witness a significant increase over the forecast period owing to surging product consumption, especially in the form of dietary supplements by the continuously increasing aging population, particularly of developed economies such as Germany, France, the Netherlands, and the UK. Moreover, the demand in the UK is largely driven by the continuous introduction of innovative products in the market. For instance, in April 2025, Epax has launched EPAX Evolve 05 the world’s first commercially available VLC-PUFA (very long chain polyunsaturated fatty acid) product. VLC-PUFAs are a family of Omega-3 fatty acids that offer particular potential in the healthy ageing category. The launch highlights the continuous innovation in omega-3 products in Europe.

Asia Pacific Omega 3 Market Trends

Asia Pacific is likely to witness growth owing to the rising demand for packaged baby nutrition formulas owing to the increasing participation of women in the workplace is anticipated to propel the demand for infant formulas in countries such as India, China, Japan, Australia, and Thailand. Furthermore, the increasing significance of omega 3 DHA for the development of the infant nervous system, vision, and brain along with the product’s ability to support long-term health is projected to drive market growth in the coming years.

Key Omega 3 Market Companies Insights

Growing consumption of the product in various applications coupled with rising awareness regarding health and chronic diseases, and regulations favoring the use of omega-3 in infant formulations has influenced manufacturers to invest in technologies and product development to meet consumer demands. The market has been experiencing an increase in new entrants across the value chain, driven by growing profits and the huge market potential for manufacturers.

Key Omega 3 Market Companies

The following key companies have been profiled for this study on the omega 3 market:

• Aker Biomarine Antarctic AS

• Orkla Health

• BASF SE

• Omega Protein Corp.

• GC Reiber Oils

• Lonza

• Croda International Plc

• EPAX

• BioProcess Algae, LLC

• Koninklijke DSM N.V

Recent Developments

• In November 2025, Zinzino announced the initiation of the process to acquire 35% of Xion International Group with the aim of forming a joint venture to produce algae using bioreactors.

• In April 2026, Fermentalg launches OMEGA ΩRIGINS EPA/DHA, a new generation of omega-3-rich algal oils. The result of several years of R&D, this innovation is based on a patented fermentation process that achieves EPA and DHA concentrations unprecedented on the market, naturally, without any concentration step.

Omega 3 Market Report Scope

Global Omega 3 Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global omega 3 market report based on type, source, application, and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Docosahexaenoic acid (DHA)

  • Eicosapentaenoic acid (EPA)

  • Alpha-linolenic acid (ALA)

  • Docosapentaenoic acid (DPA)

  • Others

• Source Outlook (Revenue, USD Billion, 2021 – 2033)

  • Marine Source

    • Fish Oil

    • Algal Oil

    • Krill Oil

    • Others

  • Plant Source

    • Nuts & Seeds

    • Vegetable Oils

    • Soy

• Application Outlook (Revenue, USD Billion, 2021 – 2033)

  • Supplements & Functional Foods

  • Pharmaceuticals

  • Infant Formula

  • Animal Feed & Pet Food

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North AmericaEurope

    • U.S.

    • Canada

    • Mexico

  • • Germany

    • UK

    • France

    • Spain

    • Italy

    • The Netherlands

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • New Zealand

  • Central & South America

    • Brazil

    • Argentina

  • Middle East and Africa

    • UAE

    • South Africa